Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021226864> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W2021226864 endingPage "1030" @default.
- W2021226864 startingPage "1030" @default.
- W2021226864 abstract "The object of this paper is to compare the La Brosse test with the quantitative urinary VMA measurement (Pisano's technique). Substances whose breakdown products appear in the urine and give false positive results were eliminated from the diet. Seven hundred 24-hr urine samples belonging to 580 patients were studied. Fifty-six patients had sympathoblastomas, 15 pheochromocytomas; the remaining several pathologies were not related to a catecholamine increase. Four hundred twelve negative, 132 intermediate, and 156 positive reactions were obtained. The negative tests had normal VMA in all cases except in five urine samples (false negative) belonging to three patients with pheochromocytoma who had increased VMA (between 15.4 and 38.6 mg/24 hr). The intermediate results had normal VMA in all cases except one patient with pheochromocytoma (VMA 18.4 mg/24 hr). Among the positive tests, 70 showed increased VMA and 86 normal VMA (false positive FP). The former results belonged to 55 samples from sympathoblastoma patients and to 15 from pheochromocytoma patients. The FP occurred in 15 patients treated for sympathoblastoma and in 71 patients without any pathology associated with a catecholamine increase. Of the sympathoblastoma patients, 30 were studied before any treatment (group I) and 26 after treatment (group II). In group I, all but 1 yielded positive tests: 28 had increased VMA and 2 had normal VMA. From this group, 16 patients were followed during treatment: 11 continued with positive tests and increased VMA excretions and 5 converted to negative tests and normal VMA. In group II, 19 were negative, 4 were intermediate, and 3, all with normal VMA, were positive. Only one patient persisted with positive tests in the subsequent evaluations. In conclusion, the La Brosse test is a practical screening test to detect and follow the course of treatment in patients with sympathoblastoma who initially had positive tests and increased VMA. All these results must be interpreted with caution because there are false positive results and a 15% of sympathoblastoma patients have normal VMA. The false negative results (1.2%) were observed in 17% of pheochromocytoma patients. The intermediate reactions were associated with normal VMA excretions except in one pheochromocytoma patient." @default.
- W2021226864 created "2016-06-24" @default.
- W2021226864 creator A5001557860 @default.
- W2021226864 creator A5007603152 @default.
- W2021226864 creator A5031279877 @default.
- W2021226864 creator A5062378419 @default.
- W2021226864 date "1978-10-01" @default.
- W2021226864 modified "2023-10-18" @default.
- W2021226864 title "Study of the La Brosse Spot Test for 3-Methoxy-4-hydroxymandelic Acid (VMA)" @default.
- W2021226864 doi "https://doi.org/10.1203/00006450-197810000-00030" @default.
- W2021226864 hasPublicationYear "1978" @default.
- W2021226864 type Work @default.
- W2021226864 sameAs 2021226864 @default.
- W2021226864 citedByCount "0" @default.
- W2021226864 crossrefType "journal-article" @default.
- W2021226864 hasAuthorship W2021226864A5001557860 @default.
- W2021226864 hasAuthorship W2021226864A5007603152 @default.
- W2021226864 hasAuthorship W2021226864A5031279877 @default.
- W2021226864 hasAuthorship W2021226864A5062378419 @default.
- W2021226864 hasBestOaLocation W20212268641 @default.
- W2021226864 hasConcept C126322002 @default.
- W2021226864 hasConcept C126894567 @default.
- W2021226864 hasConcept C2779512018 @default.
- W2021226864 hasConcept C2780026642 @default.
- W2021226864 hasConcept C71924100 @default.
- W2021226864 hasConcept C77411442 @default.
- W2021226864 hasConcept C90924648 @default.
- W2021226864 hasConceptScore W2021226864C126322002 @default.
- W2021226864 hasConceptScore W2021226864C126894567 @default.
- W2021226864 hasConceptScore W2021226864C2779512018 @default.
- W2021226864 hasConceptScore W2021226864C2780026642 @default.
- W2021226864 hasConceptScore W2021226864C71924100 @default.
- W2021226864 hasConceptScore W2021226864C77411442 @default.
- W2021226864 hasConceptScore W2021226864C90924648 @default.
- W2021226864 hasIssue "10" @default.
- W2021226864 hasLocation W20212268641 @default.
- W2021226864 hasOpenAccess W2021226864 @default.
- W2021226864 hasPrimaryLocation W20212268641 @default.
- W2021226864 hasRelatedWork W1420833956 @default.
- W2021226864 hasRelatedWork W2015291356 @default.
- W2021226864 hasRelatedWork W2025722779 @default.
- W2021226864 hasRelatedWork W2071030390 @default.
- W2021226864 hasRelatedWork W2120561004 @default.
- W2021226864 hasRelatedWork W2315748116 @default.
- W2021226864 hasRelatedWork W2369552721 @default.
- W2021226864 hasRelatedWork W2597894820 @default.
- W2021226864 hasRelatedWork W2983014931 @default.
- W2021226864 hasRelatedWork W4210649894 @default.
- W2021226864 hasVolume "12" @default.
- W2021226864 isParatext "false" @default.
- W2021226864 isRetracted "false" @default.
- W2021226864 magId "2021226864" @default.
- W2021226864 workType "article" @default.